<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Yale J Biol Med</journal-id><journal-id journal-id-type="pmc">yjbm</journal-id><journal-title>The Yale Journal of Biology and Medicine</journal-title><issn pub-type="ppub">0044-0086</issn><issn pub-type="epub">1551-4056</issn><publisher><publisher-name>Yale Journal of Biology and Medicine</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">2556863</article-id><article-id pub-id-type="pmc">2589085</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Borderline ovarian tumors: a review of treatment.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chambers</surname><given-names>J. T.</given-names></name></contrib></contrib-group><aff>Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06510.</aff><pub-date pub-type="ppub"><season>Jul-Aug</season><year>1989</year></pub-date><volume>62</volume><issue>4</issue><fpage>351</fpage><lpage>365</lpage><abstract><p>Borderline ovarian tumors have an excellent prognosis. In stage I disease, no therapy in addition to surgery is needed, and conservation of ovarian tissue for future childbearing may be appropriate. In advanced stages, the use of adjuvant therapy has not consistently led to cures, and complications have been reported. A randomized study of no adjuvant therapy versus adjuvant treatment with long-term follow-up will be necessary to determine the efficacy of additional treatment.</p></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="yjbm00070-0014.tif" xlink:title="scanned-page" xlink:role="351" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0015.tif" xlink:title="scanned-page" xlink:role="352" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0016.tif" xlink:title="scanned-page" xlink:role="353" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0017.tif" xlink:title="scanned-page" xlink:role="354" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0018.tif" xlink:title="scanned-page" xlink:role="355" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0019.tif" xlink:title="scanned-page" xlink:role="356" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0020.tif" xlink:title="scanned-page" xlink:role="357" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0021.tif" xlink:title="scanned-page" xlink:role="358" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0022.tif" xlink:title="scanned-page" xlink:role="359" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0023.tif" xlink:title="scanned-page" xlink:role="360" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0024.tif" xlink:title="scanned-page" xlink:role="361" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0025.tif" xlink:title="scanned-page" xlink:role="362" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0026.tif" xlink:title="scanned-page" xlink:role="363" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0027.tif" xlink:title="scanned-page" xlink:role="364" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="yjbm00070-0028.tif" xlink:title="scanned-page" xlink:role="365" mimetype="image" mime-subtype="tiff"/></supplementary-material></body></article>

